RFA: Pathways and Targets for Promoting Physiologic Beta Cell Regeneration

Agency: 
JDRF

The purpose of this RFA is to invite outstanding proposals to identify and characterize novel drug targets or biochemical intervention points that will promote regeneration or expansion of beta cell mass in a highly selective, safe, and specific manner. Mechanistic studies may be proposed if they are specific to the beta cell and aimed at providing insight into druggable targets that may provide a basis for translation to a drug discovery platform. Validation of the relevance to human beta cell regeneration is a priority.

Deadline: 
June 30, 2011

Last updated April 15, 2011